Iconix Pharmaceuticals, Inc.

Iconix is a chemical genetics drug company founded to advance the application of genomics to the discovery and development of drugs for the improved treatment of human diseases through the use of chemistry to define gene function and disease relevance, and the use of surrogate genetics to rapidly identify chemical modulators and drug leads for genes of known and unknown function. In its first major collaborative partnership with Microcide, Iconix has begun drug screening for viral disease targets for a number of clinically relevant human viral pathogens, including Hepatitis B and C, Herpesviruses, and Influenza.

Activity:

- Other Industry Services

Product / Technology type(s) covered:

- Bio

Therapeutic targets:

- Genetics

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: